GeneralConnection.com ➔ Dictionary
Dictionary Search

myasthenia

Synonyms

Noun

1. myasthenia gravis

2. disease of the neuromuscular junction, physiological state

3. physiological condition

Usage
FDA Grants Priority Review to Cemdisiran for Generalized Myasthenia Gravis - Ophthalmology Advisor
Seeing beyond the surface: understanding the impact of ocular symptoms in myasthenia gravis - UCB
Correcting congenital myasthenia-associated acetylcholine receptor defects - Nature
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S. - PR Newswire
Risk of Myasthenia Gravis Exacerbation During Pregnancy and Postpartum - Neurology® Journals
Diabetes may worsen MG by activating antibody-producing cells - Myasthenia Gravis News
Q&A: Expanding Treatment to the Full Spectrum of Myasthenia Gravis - Physician's Weekly
Dianthus Therapeutics (DNTH) Starts Phase 3 EMERGE Trial, Is The Upside Already Priced In? - simplywall.st
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis - NeurologyLive
This Profitable Autoimmune Biotech Trades Near A High And A Buy Point - Investor's Business Daily
UNC Study Shows CAR T-Cell Therapy Improves Symptoms of Myasthenia Gravis - UNC Health
A man’s family says he was misdiagnosed at CT hospitals. He died just weeks later. - Hartford Courant
FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis - Muscular Dystrophy Association
Do You Need To Avoid Certain Medications When You Have Myasthenia Gravis? - Cleveland Clinic Health Essentials
Efficacy of Pyridostigmine in Myasthenia Gravis - Neurology® Journals
Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma - Nature
Evaluating Oral BTK Inhibitor Remibrutinib in Phase 3 Study for Generalized Myasthenia Gravis: The RELIEVE Trial - NeurologyLive
Global clinical trial launches to test self-given, long-acting gMG drug - Myasthenia Gravis News
Comparative Study of Sporadic and Immune Checkpoint Inhibitor–Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome - Neurology® Journals
Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis - Neurology® Journals
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial - Nature
Long-Term Steroid Use Raises Health Risks in Myasthenia Gravis - Docwire News
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial - The Lancet
Efgartigimod Gains FDA Approval as First Treatment for Seronegative Forms of Myasthenia Gravis - NeurologyLive
UCB Says Long-Term Rozanolixizumab Shows Consistent Benefit in Generalized Myasthenia Gravis - TradingView
Outcomes in Relation to the Age at Onset in Patients With Myasthenia Gravis - Neurology® Journals
Physical and respiratory training in patients with myasthenia gravis: a systematic review with meta-analysis - Nature
Myasthenia Gravis Linked to Higher Infection and Cancer Risks - Docwire News
No Increased Risk of Exacerbation Seen in Myasthenia Gravis During Pregnancy - Neurology Today
Journal of Internal Medicine - Wiley Online Library
Srikanth Muppidi, MD, on Evaluating Miv-Cel in Myasthenia Gravis - CGTLive®
Efgartigimod Shows Efficacy for Long-Term Management of Myasthenia Gravis - Docwire News
How To Conserve Your Energy With Myasthenia Gravis - Cleveland Clinic Health Essentials
Tofacitinib Offers Novel Approach for Treating Refractory Myasthenia Gravis Patients - Docwire News
FDA Clears Efgartigimod for All Adult Patients With Myasthenia Gravis - Journal of Managed Care
Complexity in Myasthenia Gravis: Bridging the Gaps in Diagnosis, Treatment, and Equitable Care - NeurologyLive
Evaluating CAR-T Miv-Cel in Myasthenia Gravis - NeurologyLive
New frontiers in myasthenia gravis therapy: FcRN inhibitors, complement inhibitors and anti-CD-19 therapy - Mayo Clinic Press
Cemdisiran Shows Therapeutic Potential in Phase 3 NIMBLE Trial for Generalized Myasthenia Gravis - NeurologyLive
Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report - Cureus
Understanding Ravulizumab’s Steroid-Sparing Benefits in Generalized Myasthenia Gravis: Katherine Ruzhansky, MD, MS - NeurologyLive
Home Modifications for Myasthenia Gravis: Safety and Energy Tips - Everyday Health
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment - NeurologyLive
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Generalized myasthenia gravis: Steroid-sparing strategies for symptom relief while minimizing long-term side effects - Mayo Clinic Press
UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting - PR Newswire
How to stay active if you have myasthenia gravis - Mayo Clinic Press
Association of steroid regimens and withdrawal with relapse risk in myasthenia gravis: a real-world cohort study - Frontiers
Thymoma Type B2 Associated with Myasthenia Gravis Presenting as Progressive Respiratory Distress: A Case Report - Cureus
Comparing Long-Term Infection Risk Across Treatments for Generalized Myasthenia Gravis: Svetlana Faktorovich, MD - NeurologyLive
Juvenile myasthenia gravis: Inside one adolescent’s journey - Johnson & Johnson
UConn Health’s Myasthenia Gravis Program: Giving Patients their Life Back - UConn Today
Vemircopan Misses Primary End Point in Phase 2 Trial of Generalized Myasthenia Gravis - NeurologyLive
Progressive Bulbar Weakness in an Older Male With Suspected Double-Seronegative Myasthenia Gravis Culminating in Myasthenic Crisis: A Case Report - Cureus
Study Confirms Modest but Meaningful Benefit of Pyridostigmine in Myasthenia Gravis - Neurology Today
Germinal Centers Linked With Poor Outcomes in Thymoma-Associated Myasthenia Gravis - Docwire News
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case–Control Study - Wiley Online Library
Therapeutic approach to myasthenia gravis treatment in the era of new biologics — review of existing and upcoming therapies | Sobieszczuk | Neurologia i Neurochirurgia Polska - Via Medica Journals
Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing - Neurology® Journals
Will pregnancy make myasthenia gravis worse? Study sheds new light - healthcare-in-europe.com
Myasthenia Gravis Updates From AAN 2026 - Medscape
MHRA Approves Nipocalimab for Myasthenia Gravis - Medscape
Efgartigimod Alfa–Hyaluronidase Improves Ocular Myasthenia Gravis Symptoms - Medical Professionals Reference
Bulbar Onset Generalized Myasthenia Gravis in an Elderly Patient: A Diagnostic Challenge - Cureus
Platelet activation plays a pro-inflammatory role in myasthenia gravis - Nature
Myasthenia Gravis Outcomes Equal Across Thymectomy Types - Docwire News
Myasthenia gravis and community-acquired pneumonia: therapeutic challenges - Frontiers
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Efgartigimod Effective in Treating Juvenile Myasthenia Gravis - Journal of Managed Care
mRNA-based CAR-T therapy reduces symptom expression in myasthenia gravis - RegMedNet
Gefurulimab demonstrates statistically significant and clinically meaningful improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) at week 26 with clinically meaningful improvement seen as early as week one in adults with gMG in PREVAIL Pha - AstraZeneca
Single‑Port Robotic Thymectomy Reduces Pain and Speeds Recovery for Myasthenia Gravis Patients - University of Miami
New National Program Targets Nutrition Access in Myasthenia Gravis Community - NeurologyLive
Sugammadex Speeds Anesthesia Recovery in Myasthenia Gravis - Docwire News
Statins May Reduce Mortality Despite Myasthenia Gravis Flare Risk - Docwire News
Emerging Therapies in Myasthenia Gravis - NeurologyLive
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis - NeurologyLive
Navigating Anxiety Management in Myasthenia Gravis Crisis With Prolonged Corrected QT (QTc): A Case Report - Cureus
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD - The Lancet
Newer Myasthenia Gravis Treatments - Everyday Health
Worse Cardiac Surgery Outcomes Seen in Patients With Myasthenia Gravis - Journal of Managed Care
CAR T Promises Longer Relief For Myasthenia Gravis - Forbes
Targeting Neonatal Fc Receptor in Myasthenia Gravis - Neurology Advisor
Efgartigimod Treatment of Myasthenia Gravis Yields Heterogeneous Response - Docwire News
FDA Approves Inebilizumab for Generalized Myasthenia Gravis - Journal of Managed Care
Computed Tomography Assessment of Diaphragm Thickness in Myasthenia Gravis With Clinical and Functional Correlations - Cureus
Case Report and literature review: immune checkpoint inhibitor-associated myasthenia gravis and myocarditis - Frontiers
Platelet‑to‑Lymphocyte Ratio Predicts Severe Myasthenia Gravis - Docwire News
Acute Medicine & Surgery | JAAM Journal - Wiley Online Library
Closing the Gap Between Innovation and Access in Myasthenia Gravis Care - Euractiv
Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report - Cureus
Myasthenia-Like Presentations Following PD-1 Inhibitors: CD8+ Myositis, Myasthenia, or Both? - Cureus
Advancing Treatment Options for Pediatric Myasthenia Gravis: A Q&A With Jonathan Strober, MD - Journal of Managed Care
AAN 2026: Redefining Success in Myasthenia Gravis - Medscape
Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans - World Federation of Neurology
Disease Severity in MuSK Myasthenia Gravis Could Correlate to Antibody Levels - Journal of Managed Care
Myasthenia Gravis Foundation of America Launches MGFA Food Support Program to Advance Nutrition Access and Health Equity for Individuals with Myasthenia Gravis - PR Newswire
Preoperative Management of Patients With Myasthenia Gravis: A Review of the Evidence - Cambridge University Press & Assessment
Managing MG Fatigue: Why Symptoms Change and How to Cope - Everyday Health
Thymus research in relation to myasthenia gravis: a new perspective on cell subpopulations and future directions - Frontiers
Foreign Language Equivalents
Foreign Language Equivalents of 'myasthenia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
myastheniaa,   myathenia,   myastheina,   maysthenia,   myasthwnia,   ymasthenia,   myashtenia,   myasthenai,   mysthenia,   mysathenia,   myastjenia,   myasrhenia,   myasthennia,   myastenia,   myasthemia,   myastthenia,   myasthnia,   myasthebia,   myaasthenia,   myastehnia,   myssthenia,   myatshenia,   myasthenis,   muasthenia,   yasthenia,   myastheia,   ,yasthenia,   masthenia,   nyasthenia,   myasthrnia,   myasthenua,   myasthhenia,   myyasthenia,   myastheniia,   myastheenia,   myasyhenia,   myastgenia,   mmyasthenia,   myasthneia,   myadthenia,   mtasthenia,   myashenia,   myasthena,   myassthenia,   myastheni,   myaathenia,   myasthenoa
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z